These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10366813

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 24. [Polymorphism analysis of 5' promotor region of BCR gene].
    Tian H, Zheng WY, Fu YG, Lin JH, Lu FJ, Zhou SY.
    Ai Zheng; 2004 Jul; 23(7):812-5. PubMed ID: 15248918
    [Abstract] [Full Text] [Related]

  • 25. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G, Cignetti A, Panuzzo C, Kuka M, Vitaggio K, Brancaccio M, Perrone G, Rinaldi M, Prato G, Fava M, Geuna M, Pautasso M, Casnici C, Signori E, Tonon G, Tarone G, Marelli O, Fazio VM, Saglio G.
    Cancer Res; 2007 Jun 01; 67(11):5300-7. PubMed ID: 17545610
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. e19a2-positive chronic myeloid leukaemia with BCR exon e16-deleted transcripts.
    Wang L, Seale J, Woodcock BE, Clark RE.
    Leukemia; 2002 Aug 01; 16(8):1562-3. PubMed ID: 12145699
    [No Abstract] [Full Text] [Related]

  • 28. Murine models for human chronic myelogenous leukemia.
    Rosenberg N.
    Cancer Cells; 1990 Aug 01; 2(8-9):284-6. PubMed ID: 2223391
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Foroni L, Gerrard G, Nna E, Khorashad JS, Stevens D, Swale B, Milojkovic D, Reid A, Goldman J, Marin D.
    Am J Hematol; 2009 Aug 01; 84(8):517-22. PubMed ID: 19544476
    [Abstract] [Full Text] [Related]

  • 33. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S, Chai YB, Liu F, Zhang XY, Jia W, Xie X, Yu WQ, Shang ZC, Jin BQ, Sun BZ.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 19; 85(3):198-202. PubMed ID: 15854468
    [Abstract] [Full Text] [Related]

  • 34. [Detection of BCR-ABL gene sequences using RT-PCR in patients with leukemia in the IX region. Chile].
    Artigas CG, Melo A, Roa JC, Páez E, Vittini C, Arriagada M, González L, Pflaumer E, Roa I.
    Rev Med Chil; 2002 Jun 19; 130(6):623-30. PubMed ID: 12194684
    [Abstract] [Full Text] [Related]

  • 35. Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells.
    Nimmanapalli R, Bali P, O'Bryan E, Fuino L, Guo F, Wu J, Houghton P, Bhalla K.
    Cancer Res; 2003 Nov 15; 63(22):7950-8. PubMed ID: 14633726
    [Abstract] [Full Text] [Related]

  • 36. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.
    Ter Arkh; 2007 Nov 15; 79(4):49-53. PubMed ID: 17564019
    [Abstract] [Full Text] [Related]

  • 37. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH, Tang JL, Chen RL, Li CC, Lee CP.
    Leuk Res; 2008 Nov 15; 32(11):1724-34. PubMed ID: 18603297
    [Abstract] [Full Text] [Related]

  • 38. [New breakpoints of t(9;22) translocation in chronic myeloid leukemia].
    Misiurin AV, Surin VL, Tagiev AF.
    Bioorg Khim; 1999 Mar 15; 25(3):234-6. PubMed ID: 10382043
    [No Abstract] [Full Text] [Related]

  • 39. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P, Giuliani N.
    Haematologica; 2004 May 15; 89(5):611-3. PubMed ID: 15136228
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.